Qizhizhi data shows that Beijing Molecular Heart Technology Co., Ltd. was established on January 20, 2022, with a registered capital of 7.946981 million yuan and 14 insured persons. It is a company mainly engaged in technology promotion and application services. of enterprises. The company has been awarded qualifications and honors such as "National Science and Technology Small and Medium-sized Enterprises" and has a certain scale and strength.
In terms of intellectual property rights, Beijing Molecular Heart Technology Co., Ltd. has 3 registered trademarks, 9 software copyrights, and 5 patent information. In addition, Beijing Molecular Heart Technology Co., Ltd. also directly controls one company.
If you want to know more about Beijing Molecular Heart Technology Co., Ltd., go to Shangqi.com - search companies, bosses, risks, and business opportunities for free